Abstract
Background
The aim of the study was to compare plasma motilin-like immunoreactivity (MOT-LI) and neuropeptide Y (NPY)-like immunoreactivity (NPY-LI) in patients with functional dyspepsia (FD) during a controlled psychophysiological experiment.
Method
25 patients (12 men, 13 women), age 24–50, with recurrent FD, and 25 pair-wise sex- and age-matched community control subjects were studied. In an experiment, after a rest period, subjects were studied during a 15-min stress interview. The aim of the interview was to elicit anxiety. Before and during the intervention blood samples were drawn for peptide analyses. Outcome measures were the Gastrointestinal Symptom Rating Scale, fasting blood glucose, heart rate and blood pressure as well as the subjects’ self-ratings on visual analogue scales. The plasma concentrations of MOT-LI and NPY-LI are given as anti-logarithms.
Results
Mean plasma MOT-LI concentration was 7.3 (CI: 5.7–9.4) pmol/L in the patient group, and 7.9 (CI: 6.1–10.2) pmol/L in the control group. Mean plasma NPY-LI concentration was 14.2 (CI: 12.3–16.4) pmol/L in the patient group, and 13.4 (CI: 11.8–15.3) pmol/L in the control group. Using ANCOVA (covariates: group, gender, age, body mass index and smoking) MOT-LI was related to lower indigestion symptomatology (p<0.04) and positive change in joyfulness during the interview (p<0.03). In the patient group delta motilin correlated with increased joyfulness (p<0.03) and decreased sadness (p<0.03). The NPY-LI increase during the interview was related to higher fasting blood glucose before the interview (p<0.01) and a stronger increase in systolic blood pressure during the test (p<0.05). Conclusion: During a stress interview plasma MOT-LI is positively related to less indigestion symptomatology and joyfulness, while changes in plasma NPY-LI were positively related to sympathetic nervous system activity, but not to gastrointestinal symptoms.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Almy TP. The stress interview: unfinished business. J Human Stress 1978:4(4):3–8.
Colin-Jones DG: Management of dyspepsia: Report of a working party. Lancet 1988;i:576–579.
Dimenäs E., Glise H., Hallerbäck B., Hernqvist H., Svedlund J., Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J. Gastroenterol 1995;30:1046–1052.
Dimsdale J.E., Stern M.J., Dillon E. The stress interview as a tool for examining physical reactivity. Psychosom Med 1988;50:64–71.
Fukudo S., Suzuki J. Colonic motility, autonomic function, and gastrointestinal hormones under psychological stress on irritable bowel syndrome. Tohoku J Exp Med 1987;151:373–385.
Gotthard R., Bodemar G., Brodin U., Jösson K-Å. Treatment with cimetidine, antacids, or placebo in patients with dyspepsia of unknown origin. Scand J Gastroenterol 1988;23:7–18.
Haug T.T., Svebak S., Hausken T. et al. Low vagal activity as mediating mechanism for the relationship between personality factors and gastric symptoms in functional dyspepsia. Psychosom Med 1994;56:181–186.
Hausken T., Svebak S., Wilhelmsen I. et al. Low vagal tone and antral dysmotility in patients with functional dyspepsia. Psychosom Med 1993;55:12–22.
Jones R.H., Lydeard S.E., Hobbs FDR. et al. Dyspepsia in England and Scotland. Gut 1990;31:401–405.
Jonsson B.H., Uvnäs-Moberg K., Theorell T., Gotthard R. Gastrin, cholecystokinin, and somatostatin in a laboratory experiment of patients with functional dyspepsia. Psychosome Med 1998;60:331–337.
Jonsson B.H., Theorell T. Low plasma prolactin levels in patients with functional dyspepsia. Psychother Psychosom 1999;68:151–156.
Jonsson B.H., Theorell T., Gotthard R. Symptoms and personality in patients with chronic functional dyspepsia. J Psychosom Res 1995;39:93–102.
Koskenpato J., Kairemo K., Korppi-Tommola T. et al. Role of gastric emptying in functional dyspepsia. A scintigraphic study of 94 subjects. Dig Dis Sci 1998;43:1154–1158.
Kusano M., Sekiguchi T., Kawamura O. et al. Further classification of dysmotility-like dyspepsia by interdigestive gastroduodenal manometry and plasma motilin level. Am J Gastroenterol 1997;92:481–484.
Labó G., Bortolotti M., Vezzadini P., Bonora G., Bersani G. Interdigestive gastroduodenal motility and serum motilin levels in patients with idiopathic delay in gastric emptying. Gastroenterology 1986;90:20–26.
Lördal M., Theodorsson E., Hellström P.M. Tachykinins influence interdigestive rhythm and contractile strength of human small intestine. Dig Dis Sci 1997;42:1940–1949.
Malagelada J-R. Gastrointestinal motor disturbances in functional dyspepsia. Scand J Gastroenterol 1991;26 (Suppl. 182):29–32.
Mittelmann B., Wolf H.G. Emotions and gastroduodenal function. Experimental studies on patients with gastritis, duodentitis and peptic ulcer. Psychosom Med 1942;4:5–61.
Morris M.J., Cox H.S., Lambert G.W. et al. Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans. Hypertension 1997;29:137–143.
Näslund E., Backman L., Theodorsson E., Hellström P.M. Intraduodenal neuropeptide levels, but not plasma levels, vary in a cyclic fashion with the migrating motor complex. Acta Physiol Scand 1998;164:317–323.
Sjölund K., Ekman R., Lindgren S., Rehfeld J.F. Disturbed motilin and cholecystokinin release in the irritable bowel syndrome. Scand J Gastroenterol 1996;31:1110–1114.
Svedlund J., Sjödin I., Dotevall G. GSRS—A clinical rating scale for gastro-intestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988;33:129–134.
Svensson J.C., Theorell T. Cardiovascular effects of anxiety induced by interviewing young hypertensive male subjects. J Psychosom Res, (1982);26:359–370.
Talley N.J., Colin-Jones D., Koch K.J., Koch M., Nyrén O., Stanghellini V. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterol Intl 1991;4:145–160.
Talley N.J., Zinsmeister A.R., Schleck C.D. et al. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992;102:1259–1268.
Talley N.J. Scope of the problem of functional digestive disorders. Eur J Surg 1998;164 (Suppl. 582):35–41.
Theodorsson-Norheim E., Hemsén A., Lundberg J.M. Radioimmunoassay for neuropeptide Y (NPY): chromatographic characterization of immunoreactivity in plasma and tissue extracts. Scand J Clin Lab Invest 1985;45:355–365.
Thompson D.G. Modulation of gastric perception and motility of man. Current concepts and correlation with symptoms. Dig Dis Sci 1994;39:48S-50S.
Uvnäs-Moberg K. Gastrointestinal hormones and pathophysiology of functional gastrointestinal disoders. Scand J Gastroenterol 1987;22 (Suppl. 128):138–146.
Zukowska-Grojec Z. Neuropeptide Y. A novel sympathetic stress hormone and more. Ann N Y Acad Sci 1995;771:219–233.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jonsson, B.H., Hellström, P.M. Motilin-and neuropeptide Y-like immunoreactivity in a psychophysiological stress experiment on patients with functional dyspepsia. Integrative Physiological and Behavioral Science 35, 256–265 (2000). https://doi.org/10.1007/BF02688788
Issue Date:
DOI: https://doi.org/10.1007/BF02688788